Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (1724)	12/4/1999 5:03:00 PM
From: Bill Wexler	Read Replies (3) \| Respond to of 5582

Of course the GUMM shills will counter that Ziscam is "different" because it is sprayed up the nose. Interesting that there is zero evidence to confirm the dubious claims made by Gel-tech that Zicam "blocks" or somehow interferes with the Rhinovirus. Results of their rigged "clinical trials" were rejected for publication, yet GUMM's crooked management issued a press release that publication was imminent. Only a matter of time before the FTC shuts down this fraud - just like Quigley.

To: RockyBalboa who wrote (1724)	12/4/1999 6:29:00 PM
From: DanZ	Respond to of 5582

IS: The clinically proven claim that Quigley cites is true because the independent clinical study for Zicam has not been published yet. The claims that Gum Tech is currently making for Zicam are supported by their first study. Their law firm is highly respected in FTC issues related to health care products and this is their opinion. Quigley would not be able to claim that they have the only product that is clinically proven to reduce the duration and severity of common cold symptoms after the second study is released. In fact, Gum Tech could claim that Zicam is clinically proven to be more effective than Cold Eeze at that time. I don't see how you can conclude that Zicam doesn't work from Quigley's press release.